JIANG Haoyue, YU Shujun, TANG Yibo, SHEN Zhenru, LIU Zhejun, TANG Tian, WANG Shuaiqiang, TONG Kejin, LIU Zhenquan. Meta-analysis of efficacy of Shengjing Capsules (Tablets) in the treatment of oligoasthenospermia[J]. Journal of Clinical Medicine in Practice, 2022, 26(21): 46-54. DOI: 10.7619/jcmp.20222610
Citation: JIANG Haoyue, YU Shujun, TANG Yibo, SHEN Zhenru, LIU Zhejun, TANG Tian, WANG Shuaiqiang, TONG Kejin, LIU Zhenquan. Meta-analysis of efficacy of Shengjing Capsules (Tablets) in the treatment of oligoasthenospermia[J]. Journal of Clinical Medicine in Practice, 2022, 26(21): 46-54. DOI: 10.7619/jcmp.20222610

Meta-analysis of efficacy of Shengjing Capsules (Tablets) in the treatment of oligoasthenospermia

More Information
  • Received Date: August 22, 2022
  • Available Online: November 07, 2022
  • Objective 

    To systematically review the effectiveness of Shengjing Capsules (Tablets) in the treatment of oligoasthenozoospermia.

    Methods 

    The random controlled trials (RCT) of Shengjing Capsules (Tablets) in treating oligoasthenospermia in China National Knowledge Infrastructure (CNKI), Wanfang Data Knowledge Service Platform (Wanfang Data), China Science and Technology Journal Database(VIP), the Cochrane Library and PubMed were searched by computers, and the search time was from the establishment of the database to August 9, 2022. Literature review was conducted by two researchers according to the search methods, and the literatures were screened for inclusion and exclusion. RevMan 5.4 software was used for meta-analysis.

    Results 

    A total of 26 literatures were included, with a total of 2 902 samples. Meta-analysis result show that the total effective rate of trail group treated with Shengjing Capsules (Tablets) was significantly higher than that of the control group(RR=1.41, 95%CI, 1.25 to 1.60, P < 0.000 01), and the improvementsin semen volume (MD=0.50, 95%CI, 0.30 to 0.71, P < 0.000 01), semen density(MD=12.39, 95%CI, 9.19 to15.59, P < 0.000 01), sperm rate ofgrade a (MD=7.24, 95%CI, 4.39 to 10.08, P < 0.000 01) and sperm rate of gradea plus b(MD=9.00, 95%CI, 3.25 to 18.15, P < 0.000 01) were significantly better than those of the control group.

    Conclusion 

    Meta-analysis study shows that Shengjing Capsules (Tablets) is effective in the treatment of oligoasthenospermia, but we still need more RCTs with high quality and large samples to provide high-level evidence-based medical data.

  • [1]
    JIANG Z H, ZHOU B, LI X P, et al. Echinacosideincreases sperm quantity in rats by targeting the hypothalamic androgen receptor[J]. Sci Rep, 2018, 8(1): 3839. doi: 10.1038/s41598-018-22211-1
    [2]
    COOPER T G, NOONAN E, VON ECKARDSTEIN S, et al. World Health Organization reference values for human semen characteristics[J]. Hum Reprod Update, 2010, 16(3): 231-245. doi: 10.1093/humupd/dmp048
    [3]
    TOURNAYE H. Male factor infertility and ART[J]. Asian J Androl, 2012, 14(1): 103-108.
    [4]
    JENSEN C F S, ØSTERGREN P, DUPREE J M, et al. Varicocele and male infertility[J]. Nat Rev Urol, 2017, 14(9): 523-533.
    [5]
    王福, 俞旭君. 生精胶囊在男性不育症中的临床应用中国专家共识[J]. 中华男科学杂志, 2019, 25(4): 368-371. doi: 10.13263/j.cnki.nja.2019.04.015
    [6]
    赵罗娜, 张永萍, 刘明, 等. 生精胶囊中冬虫夏草替代物及生精的相关药效研究[J]. 中华男科学杂志, 2018, 24(7): 627-634. doi: 10.13263/j.cnki.nja.2018.07.009
    [7]
    李晖. 克罗米芬联合生精胶囊治疗少、弱精症的临床观察[J]. 中外医疗, 2011, 30(27): 128-128. doi: 10.3969/j.issn.1674-0742.2011.27.100
    [8]
    王志, 李建勇. 联合生精胶囊治疗少、弱精子症60例疗效观察[J]. 四川医学, 2009, 30(1): 124-125. doi: 10.3969/j.issn.1004-0501.2009.01.063
    [9]
    季明勇, 常德贵, 孟衍建, 等. 生精胶囊联合勃锐精治疗少弱精子症的疗效观察[J]. 中国男科学杂志, 2012, 26(4): 53-55. doi: 10.3969/j.issn.1008-0848.2012.04.016
    [10]
    曾育鑫. 生精胶囊联合维生素E治疗治疗男性不育症的疗效探讨[J]. 北方药学, 2017, 14(12): 10-11. doi: 10.3969/j.issn.1672-8351.2017.12.007
    [11]
    黄永刚, 肖宇, 黄朝霞, 等. 生精胶囊联合雄激素治疗特发性少弱精子症63例[J]. 中国药业, 2012, 21(24): 103-105. doi: 10.3969/j.issn.1006-4931.2012.24.056
    [12]
    戴继灿, 李铮, 刘勇, 等. 生精胶囊治疗男性不育症安全性和有效性探讨[J]. 中国男科学杂志, 2007, 21(9): 44-45, 50. https://www.cnki.com.cn/Article/CJFDTOTAL-NXXX200709018.htm
    [13]
    王永顺. 生精胶囊治疗男性不育症临床观察[J]. 新中医, 2013, 45(9): 42-44. https://www.cnki.com.cn/Article/CJFDTOTAL-REND201309021.htm
    [14]
    宋辉. 生精胶囊治疗男性不孕症220例临床分析[J]. 中国伤残医学, 2015, 23(7): 113-114.
    [15]
    苏宇, 陈俊. 生精胶囊治疗男性少弱精子症临床观察[J]. 新中医, 2011, 43(8): 91-92. https://www.cnki.com.cn/Article/CJFDTOTAL-REND201108050.htm
    [16]
    吴丽彩. 生精胶囊治疗轻度弱精子症30例[J]. 中国中医药现代远程教育, 2013, 11(15): 16-17. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYY201315013.htm
    [17]
    宋方闻, 钟惟德. 生精胶囊治疗少弱精子症的临床疗效观察[J]. 中华男科学杂志, 2009, 15(8): 762-764. https://www.cnki.com.cn/Article/CJFDTOTAL-NKXB200908027.htm
    [18]
    王文杰, 史宏, 张静, 等. 生精胶囊治疗少弱精子症的临床研究[J]. 广西中医药, 2017, 40(3): 1-3. https://www.cnki.com.cn/Article/CJFDTOTAL-GXZY201703001.htm
    [19]
    王田, 肖民辉, 杨小华, 等. 生精胶囊治疗少弱精子症疗效分析[J]. 中国计划生育和妇产科, 2009, 1(2): 29-30. https://www.cnki.com.cn/Article/CJFDTOTAL-NKXB200908027.htm
    [20]
    白双勇, 彭林, 欧阳武, 等. 生精胶囊治疗少弱精子症疗效观察[J]. 中国男科学杂志, 2007, 21(12): 64-65. https://www.cnki.com.cn/Article/CJFDTOTAL-NXXX200712029.htm
    [21]
    朱彤, 江培春. 生精胶囊治疗特发性少精子症30例[J]. 四川中医, 2005, 23(5): 45-46. https://www.cnki.com.cn/Article/CJFDTOTAL-SCZY200505027.htm
    [22]
    董世桃. 生精片对男性少弱精子症患者精液参数的影响[J]. 东方食疗与保健, 2015(10): 13-13, 16. https://www.cnki.com.cn/Article/CJFDTOTAL-NKXB201208022.htm
    [23]
    孙振高, 连方, 姜鲲鹏, 等. 生精片对男性少弱精子症患者精液参数的影响及作用机制研究[J]. 中华男科学杂志, 2012, 18(8): 764-767. https://www.cnki.com.cn/Article/CJFDTOTAL-NKXB201208022.htm
    [24]
    代淑静, 杨颖, 梁真, 等. 生精片联合他莫昔芬对男性弱精症患者精液参数的影响[J]. 现代中西医结合杂志, 2016, 25(15): 1642-1644, 1710. https://www.cnki.com.cn/Article/CJFDTOTAL-XDJH201615016.htm
    [25]
    吉鹏, 徐计秀, 王璟琦, 等. 生精片联合左卡尼汀治疗特发性少弱精子症的临床观察[J]. 中国现代医生, 2013, 51(4): 73-74. https://www.cnki.com.cn/Article/CJFDTOTAL-ZDYS201304036.htm
    [26]
    攸毅. 生精片联合左卡尼汀治疗特发性少弱精子症患者的效果[J]. 中国民康医学, 2020, 32(10): 59-61. https://www.cnki.com.cn/Article/CJFDTOTAL-ZMYX202010023.htm
    [27]
    曹跃龄, 杨配兰, 张琼芬. 西药配合生精胶囊治疗男性少精、弱精症60例疗效观察[J]. 云南中医中药杂志, 2010, 31(12): 31-32. https://www.cnki.com.cn/Article/CJFDTOTAL-YZYY201012019.htm
    [28]
    熊付兴, 莫晓彬. 运用生精胶囊治疗男性不育症的疗效及安全性分析[J]. 中国医学创新, 2012, 9(12): 100-101. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYCX201212064.htm
    [29]
    张明亮, 郑小挺, 张端军, 等. 中西医联合治疗特发性少弱精子症的疗效观察[J]. 现代诊断与治疗, 2018, 29(5): 697-698. https://www.cnki.com.cn/Article/CJFDTOTAL-XDZD201805013.htm
    [30]
    陈怡红, 李海文, 沙伟玲, 等. 中药治疗男性不育患者精液分析[J]. 内蒙古中医药, 2016, 35(6): 24-25. https://www.cnki.com.cn/Article/CJFDTOTAL-NZYY201606029.htm
    [31]
    袁兵, 徐敏玲, 李红. 他莫昔芬联合生精胶囊治疗少弱精子症的临床观察[J]. 中国男科学杂志, 2012, 26(7): 56-56.
    [32]
    沙漠, 王岩斌, 马超, 等. 左卡尼汀联合生精胶囊治疗男性少弱精子症临床疗效观察[J]. 医药前沿, 2017(24): 21-23.
    [33]
    邱明星, 熊国兵, 龚百生, 等. 中医药治疗前列腺炎随机对照试验的系统评价[J]. 中国循证医学杂志, 2010, 10(1): 56-72. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXZ201001016.htm
    [34]
    安琪, 邹练. 生精类中成药治疗男性少、弱精子症的Network Meta分析和系统评价[J]. 生殖与避孕, 2016, 36(1): 42-48, 74. https://www.cnki.com.cn/Article/CJFDTOTAL-SJZA202007017.htm
  • Cited by

    Periodical cited type(11)

    1. 岳佳丽,海光,雷卓颖,王丽君. 环硅酸锆钠联合肾素-血管紧张素-醛固酮系统抑制剂治疗慢性肾脏病的机制和效果的研究进展. 中国医药导报. 2024(16): 188-190 .
    2. 竹琳,郑浩天,万正红,何莉,周莉. 血液透析患者高钾血症相关领域研究热点及发展动态的可视化分析. 华西医学. 2024(08): 1259-1264 .
    3. 黄湘干,赵艳,关毅标,翁春亮,谢双燕. 维持性血液透析患者高钾血症发生的相关因素分析. 现代医学与健康研究电子杂志. 2024(21): 116-119 .
    4. 董生荣,景舒梦,苟伟康,房浩亮,刘彬彬,刘永峰. 环硅酸锆钠治疗围透析期患者慢性高钾血症的有效性研究. 中国卫生标准管理. 2023(02): 140-143 .
    5. 陈丽,常文秀. 环硅酸锆钠散治疗慢性肾脏病高钾血症的临床研究. 现代诊断与治疗. 2023(05): 700-703 .
    6. 陈文文,方芦炜,丁越越,马红珍. 马红珍教授治疗慢性肾病伴高钾血症的中药应用策略. 浙江中医药大学学报. 2023(08): 874-879 .
    7. 蔡享兰. 不同剂量肾康注射液辅助治疗慢性肾脏病3~5期的效果及对肾功能的影响. 中国医学创新. 2023(30): 49-53 .
    8. 宋欣芫,常文秀. 慢性肾脏病5期合并高钾血症饮食干预1例报告. 中国实用内科杂志. 2022(05): 438-440 .
    9. 张灿,王静. 慢性肾脏疾病患者血钾异常的影响因素及对预后的影响研究. 医药论坛杂志. 2022(13): 20-23 .
    10. 刘环,罗琰琨,王晨丹. 环硅酸锆钠散治疗慢性高钾血症1例. 中国医药. 2022(12): 1877-1879 .
    11. 丁苗佳,沈水娟,吴佳盈. 新型口服降钾药物环硅酸锆钠治疗慢性肾脏病高钾血症临床进展. 中国医药科学. 2021(21): 66-69 .

    Other cited types(6)

Catalog

    Article views (225) PDF downloads (27) Cited by(17)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return